Albino-Teixeira A - Search Results

1

Evaluation of urinary cysteinyl leukotrienes as biomarkers of severity and putative therapeutic targets in COVID-19 patients.

Reina-Couto M, Roboredo-Madeira M, Pereira-Terra P, Silva-Pereira C, Martins S, Teixeira-Santos L, Pinho D, Dias A, Cordeiro G, Dias CC, Sarmento A, Tavares M, Guimarães JT, Roncon-Albuquerque R, Paiva JA, Albino-Teixeira A, Sousa T. Reina-Couto M, et al. Among authors: albino teixeira a. Inflamm Res. 2023 Mar;72(3):475-491. doi: 10.1007/s00011-022-01682-z. Epub 2023 Jan 8. Inflamm Res. 2023. PMID: 36617343 Free PMC article.

2

Effects of sympathetic denervation on liver fibroblasts: prevention by adenosine.

Albino-Teixeira A, Matias A, Soares-da-Silva P, Sarmento A, Azevedo I. Albino-Teixeira A, et al. J Auton Pharmacol. 1990 Jun;10(3):181-9. doi: 10.1111/j.1474-8673.1990.tb00017.x. J Auton Pharmacol. 1990. PMID: 2116415

3

Amitriptyline-induced morphological alterations of the rat blood-brain barrier.

Sarmento A, Albino-Teixeira A, Azevedo I. Sarmento A, et al. Eur J Pharmacol. 1990 Jan 25;176(1):69-74. doi: 10.1016/0014-2999(90)90133-q. Eur J Pharmacol. 1990. PMID: 2311660

4

Angiotensin converting enzyme inhibition prevents trophic and hypertensive effects of an antagonist of adenosine receptors.

Sousa T, Morato M, Albino-Teixeira A. Sousa T, et al. Eur J Pharmacol. 2002 Apr 19;441(1-2):99-104. doi: 10.1016/s0014-2999(02)01488-7. Eur J Pharmacol. 2002. PMID: 12007926

5

The role of angiotensin II in hypertension due to adenosine receptors blockade.

Morato M, Sousa T, Guimarães S, Moura D, Albino-Teixeira A. Morato M, et al. Eur J Pharmacol. 2002 Nov 29;455(2-3):135-41. doi: 10.1016/s0014-2999(02)02587-6. Eur J Pharmacol. 2002. PMID: 12445579

6

Hypertension due to blockade of adenosine receptors.

Guimarães S, Morato M, Sousa T, Albino-Teixeira A. Guimarães S, et al. Pharmacol Toxicol. 2003 Apr;92(4):160-2. doi: 10.1034/j.1600-0773.2003.920404.x. Pharmacol Toxicol. 2003. PMID: 12753417 Review.

7

Scavenging of nitric oxide by an antagonist of adenosine receptors.

Sousa T, Fernandes E, Nunes C, Laranjinha J, Carvalho F, Pinho D, Morato M, Albino-Teixeira A. Sousa T, et al. J Pharm Pharmacol. 2005 Mar;57(3):399-404. doi: 10.1211/0022357055614. J Pharm Pharmacol. 2005. PMID: 15807997

8

Pre- and postjunctional effects of angiotensin II in hypertension due to adenosine receptor blockade.

Morato M, Pinho D, Sousa T, Guimarães S, Moura D, Albino-Teixeira A. Morato M, et al. Eur J Pharmacol. 2006 Feb 15;531(1-3):209-16. doi: 10.1016/j.ejphar.2005.12.009. Epub 2006 Jan 24. Eur J Pharmacol. 2006. PMID: 16438958

9

Inhibition of nociceptive responses of spinal cord neurones during hypertension involves the spinal GABAergic system and a pain modulatory center located at the caudal ventrolateral medulla.

Morato M, Pinho D, Sousa T, Tavares I, Albino-Teixeira A. Morato M, et al. J Neurosci Res. 2006 Mar;83(4):647-55. doi: 10.1002/jnr.20770. J Neurosci Res. 2006. PMID: 16453312

10

Lesion of the caudal ventrolateral medulla prevents the induction of hypertension by adenosine receptor blockade in rats.

Pinho D, Sousa T, Morato M, Tavares I, Albino-Teixeira A. Pinho D, et al. Brain Res. 2006 Feb 16;1073-1074:374-82. doi: 10.1016/j.brainres.2005.12.098. Epub 2006 Feb 2. Brain Res. 2006. PMID: 16457788

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page